azacitidine and Rhabdomyosarcoma 2

azacitidine has been researched along with Rhabdomyosarcoma 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Darvishi, E; Eddie Loh, YH; Helman, LJ; Hou, X; Hugues Parmentier, J; Mitra, S; Slemmons, K; Wan, Z	1

Other Studies

1 other study(ies) available for azacitidine and Rhabdomyosarcoma 2

Article	Year
Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas. Neoplasia (New York, N.Y.), 2020, Volume: 22, Issue:7 Topics: Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation Sequencing; Down-Regulation; Enhancer Elements, Genetic; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Nuclear Proteins; Receptor, Fibroblast Growth Factor, Type 4; Repressor Proteins; Rhabdomyosarcoma, Alveolar	2020

Article

Year

Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas.

Neoplasia (New York, N.Y.), 2020, Volume: 22, Issue:7

Topics: Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation Sequencing; Down-Regulation; Enhancer Elements, Genetic; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Nuclear Proteins; Receptor, Fibroblast Growth Factor, Type 4; Repressor Proteins; Rhabdomyosarcoma, Alveolar

2020